Bausch Health Cos Inc. (BHC-N) Stock Predictions - Stockchase
WATCH LIST
3
Bausch Health Cos Inc. (BHC-N)

ON STOCKCHASE SINCE Aug 2018

Healthcare

Bausch Health Cos Inc.

BHC-N

2 watching          
Join the Discussion

Bausch Health Cos Inc. (BHC-N) SAVE Dec, 14, 2018, 2:44 am

23.65 0.48 (1.99%)

What the experts are saying about BHC-N



  • All
  • Filtered
Signal Opinion Expert
COMMENT
R&D-to-sales metric steered him away from Valeant (what Bausch used to be named). The current CEO is doing a great job transitioning and paying debt and de-risking the company. They appear to be doing well during this restructuring.
Healthcare
0 0 0 0 0
0 comments
R&D-to-sales metric steered him away from Valeant (what Bausch used to be named). The current CEO is doing a great job transitioning and paying debt and de-risking the company. They appear to be doing well during this restructuring.
Healthcare
0 0 0 0 0
0 comments
Paul Macdonald

Chief Inve, Harvest Portfolios G...

Price Price
$25.280
Owned Owned
No

DON'T BUY
Bausch Health Cos Inc.(BHC-N) 

September 17, 2018

You have been through ups and down with this one including a name change from Valiant.  It has decent price momentum.  They are trying to reconcile their balance sheet.  Forward numbers look a lot better than backward looking numbers.  They are not cheap enough and it is still a volatile stock.  They have too much debt so avoid it.

Healthcare
0 0 0 0 0
0 comments

You have been through ups and down with this one including a name change from Valiant.  It has decent price momentum.  They are trying to reconcile their balance sheet.  Forward numbers look a lot better than backward looking numbers.  They are not cheap enough and it is still a volatile stock.  They have too much debt so avoid it.

Healthcare
0 0 0 0 0
0 comments
Jason Mann

CIO & Co-F, Edgehill Patners...

Price Price
$22.550
Owned Owned
Unknown

DON'T BUY

Formally Valiant.  It had a rise and fall from grace.  It bottomed over the last year.  There is a lot of volatility.  They addressed some of the concerns.  Investors worry about R&D; and about drugs coming off patent.  He does not know about their pipelines.  If you can handle the risk, there are few companies where you can play the sector.  There are more names in the US in this space that are attractive.

Healthcare
0 0 0 0 0
0 comments

Formally Valiant.  It had a rise and fall from grace.  It bottomed over the last year.  There is a lot of volatility.  They addressed some of the concerns.  Investors worry about R&D; and about drugs coming off patent.  He does not know about their pipelines.  If you can handle the risk, there are few companies where you can play the sector.  There are more names in the US in this space that are attractive.

Healthcare
0 0 0 0 0
0 comments
Cole Kachur

Senior Wea, ScotiaWealth Managem...

Price Price
$23.170
Owned Owned
Unknown

Showing 1 to 3 of 3 entries
Successfully Saved Company
Successfully Saved Company